Prolonged Use Of Statins Does Not Increase The Risk Of Cancer

Prolonged Use Of Statins Does Not Increase The Risk Of Cancer.

New study supports the idea that patients who take cholesterol-lowering drugs known as statins may not have an increased hazard for cancer, as some previous studies suggested. Statins are the most commonly prescribed drugs for subjects with high blood cholesterol levels, which are linked to heart disease. Brand names cover Crestor, Lipitor and Zocor going here. "Three or four years ago there was a blaze of articles pointing out that statins could produce cancer, and, at present, the most recent studies do not show this, and this is one of them," said Dr Valentin Fuster, erstwhile president of the American Heart Association and headman of Mount Sinai Heart in New York City.

This latest study, slated for award Wednesday at the annual meeting of the American Heart Association in Chicago, was conducted by researchers from S2 Statistical Solutions, Inc, a troop that does economic research for health care-related businesses; the University of California, San Diego; and GE Healthcare, a upset of General Electric, which provided the database for the study read full report. Another just out study, reported Nov 10, 2010 at a converging of the American Association for Cancer Research, also found that long-term use of statins did not increase the risk of cancer and might even de-escalation users' risks for lymphoma, melanoma and endometrial tumors.

But while research showed that short-term use of statins had illiberal effect on the risk of developing cancer, less was known about their long-term use. To get a clearer display over time, the authors of this new study pored through more than 11 million patient records over two decades (1990 to at cock crow 2009) to identify almost 46000 comparable pairs of statin and non-statin users.

The pairs were followed for an typical of eight years. Cancer occurred in 11,4 percent of almost 24000 patients during the forced time frame. Non-statin users had an incidence of 11,1 percent, essentially the same as users. But there is an indwelling problem with studying this subject, pointed out Dr John C LaRosa, president of the State University of New York Downstate Medical Center in New York City.

So "If statins keep up animation and you don't die of heart disease, you're universal to die of something else. How are you going to separate an increased peril of cancer caused by statins from the effect that statins have on coronary disease, allowing you to live longer so that a growing malignancy can aver itself clinically? "I think we may be coming to an issue that we may never know for sure" related site. Cancer and generosity disease are the leading causes of death in the United States.

tag : statins cancer heart study disease users research statin association

Post a comment

Private comment



Dr. Alejandra Falto

Новые записи
Новые комментарии
Новые трэкбэки
Архив по месяцам
Форма поиска
RSS ссылка
Формуляр приглашения в блог-друзья

Добавить автора в блог-друзья